Evolution of guidelines for respiratory cytology by the Papanicolaou Society of Cytopathology.
cytology-guidelines
lung
reporting system
respiratory tract
Journal
Diagnostic cytopathology
ISSN: 1097-0339
Titre abrégé: Diagn Cytopathol
Pays: United States
ID NLM: 8506895
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
16
12
2019
revised:
05
04
2020
accepted:
07
04
2020
pubmed:
3
5
2020
medline:
9
6
2021
entrez:
3
5
2020
Statut:
ppublish
Résumé
Cytology serves a fundamental role in the evaluation of the lower respiratory tract. Cytological specimens are often the first diagnostic attempt for the evaluation of radiographic alterations. The categorization of the pathological process as infectious, inflammatory or neoplastic is critical in guiding further clinical management of the affected patient. Therefore it is imperative that cytopathologists use a standardized approach to sample handling and reporting in order to establish clear communication with the treating physician. The Papanicolaou Society of cytopathology has been an active leader in this field and has proposed several guidelines for sampling, handling, and reporting of lower respiratory tract cytology. These guidelines have been updated to incorporate new emerging concepts and technologies in the field. Respiratory medicine is a fast growing area with constant new challenges, thus requiring an ever demanding adaptation from cytopathologists and cytology specific guidelines.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
867-869Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Guidelines of the Papanicolaou Society of Cytopathology for the examination of cytologic specimens obtained from the respiratory tract. Papanicolaou Society of Cytopathology Task Force on standards of practice. Diagn Cytopathol. 1999;21(1):61-69.
Michael CW, Hoda RS, Saqi A, et al. Committee I: indications for pulmonary cytology sampling methods. Diagn Cytopathol. 2016;44(12):1010-1023.
Michael CW, Faquin W, Jing X, et al. Committee II: guidelines for cytologic sampling techniques of lung and mediastinal lymph nodes. Diagn Cytopathol. 2018;46(10):815-825.
Layfield LJ, Baloch Z, Elsheikh T, et al. Standardized terminology and nomenclature for respiratory cytology: the Papanicolaou Society of Cytopathology guidelines. Diagn Cytopathol. 2016;44(5):399-409.
Layfield LJ, Roy-Chowdhuri S, Baloch Z, et al. Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: the papanicolaou society of cytopathology consensus recommendations for respiratory cytology. Diagn Cytopathol. 2016;44(12):1000-1009.
Buonocore DJ, Konno F, Jungbluth AA, et al. CytoLyt fixation significantly inhibits MIB1 immunoreactivity whereas alternative Ki-67 clone 30-9 is not susceptible to the inhibition: critical diagnostic implications. Cancer Cytopathol. 2019;127(10):643-649.
Sauter JL, Grogg KL, Vrana JA, Law ME, Halvorson JL, Henry MR. Young investigator challenge: validation and optimization of immunohistochemistry protocols for use on cellient cell block specimens. Cancer Cytopathol. 2016;124(2):89-100.
Roy-Chowdhuri S. Advances in molecular testing techniques in Cytologic specimens. Surg Pathol Clin. 2018;11(3):669-677.
Jain D, Roy-Chowdhuri S. Molecular pathology of lung cancer cytology specimens: a concise review. Arch Pathol Lab Med. 2018;142(9):1127-1133.